4.6 Article

Vaccine Immunopotentiators of the future

Journal

CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 82, Issue 6, Pages 750-755

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/sj.clpt.6100394

Keywords

-

Ask authors/readers for more resources

Vaccine adjuvants or immunopotentiators comprise a diverse group of molecules or formulations. Despite a wealth of different candidates, there is a need for better vaccine adjuvants in both veterinary and human medicine. For human vaccines, the immunopotentiator choice has been limited to aluminum salts, until recently. By contrast, a whole range of adjuvants is employed for inactivated veterinary vaccines, due to less stringent safety and regulatory requirements and proven superior vaccine performance. This review highlights recent developments and future trends in immunopotentiators.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available